Liquidia Shares Drop Sharply After Court Ruling in Patent Dispute with United Therapeutics
Shares of Liquidia Corp (LQDA) fell by more than half following a court ruling that denied its motion to strike in an ongoing patent dispute involving Yutrepia, one of the company's key drugs. The decision came from Judge Richard G. Andrews and has been interpreted as unfavorable for Liquidia. In contrast, United Therapeutics (UTHR) saw its stock rise by 13% after the ruling was announced, indicating a positive market reaction to the court’s stance in favor of their position in this legal battle. The outcome could have significant implications on future patent-related litigation and potential licensing agreements between the two companies.
Topics: patent_dispute stock_movement